Veterinary Medicines

Kloxerate retard vet intramammaarisuspensio, umpeenpantavalle lehmälle

Authorised
  • Cloxacillin benzathine
  • Ampicillin trihydrate
Download as PDF

Product identification

Medicine name:
Kloxerate retard vet intramammaarisuspensio, umpeenpantavalle lehmälle
Active substance:
  • Cloxacillin benzathine
  • Ampicillin trihydrate
Target species:
  • Cattle
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Cloxacillin benzathine
    500.00
    milligram(s)
    /
    1.00
    Syringe
  • Ampicillin trihydrate
    250.00
    milligram(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle
      • Meat and offal
        28
        day
      • Milk
        6
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51CR50
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Finland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Norbrook Laboratories (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Norbrook Laboratories Limited
  • Norbrook Manufacturing Limited
Responsible authority:
  • Finnish Medicines Agency
Authorisation number:
  • 11159
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Finnish (PDF)
Published on: 27/01/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Finnish (PDF)
Published on: 27/01/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."